Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system

Elek, 1974, Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero, Lancet, 1, 1, 10.1016/S0140-6736(74)92997-3 Arvin, 2004, Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee, Clin Infect Dis, 39, 233, 10.1086/421999 Fowler, 1997, Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection, J Pediatr., 130, 624, 10.1016/S0022-3476(97)70248-8 Harris, 1984, Congenital cytomegalovirus infection and sensorineural hearing loss, Ear Hear, 5, 352, 10.1097/00003446-198411000-00006 Fowler, 1999, Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed?, J Pediatr, 135, 60, 10.1016/S0022-3476(99)70328-8 Grosse, 2008, Congenital cytomegalovirus (CMV) infection as a cause of permanent bilateral hearing loss: a quantitative assessment, J Clin Virol, 41, 57, 10.1016/j.jcv.2007.09.004 Demmler, 1991, Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease, Rev Infect Dis, 13, 315, 10.1093/clinids/13.2.315 Stagno, 1985, Herpesvirus infections of pregnancy. Part I. Cytomegalovirus and Epstein-Barr virus infections, N Engl J Med, 313, 1270, 10.1056/NEJM198511143132006 McCracken, 1969, Congenital cytomegalic inclusion disease A longitudinal study of 20 patients, Am J Dis Child., 117, 522, 10.1001/archpedi.1969.02100030524005 Pass, 1980, Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up, Pediatrics, 66, 758, 10.1542/peds.66.5.758 Weller, 1971, The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. I, N Engl J Med, 285, 203, 10.1056/NEJM197107222850406 Weller, 1962, Virologic and clinical observations on cytomegalic inclusion disease, N Engl J Med, 266, 1233, 10.1056/NEJM196206142662401 Conboy, 1987, Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection, J Pediatr, 111, 343, 10.1016/S0022-3476(87)80451-1 Dollard, 2007, New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection, Rev Med Virol, 10.1002/rmv.544 Yow, 1992, Congenital cytomegalovirus disease—20 years is long enough, N Engl J Med, 326, 702, 10.1056/NEJM199203053261010 Kimberlin, 2003, Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial, J Pediatr, 143, 16, 10.1016/S0022-3476(03)00192-6 Frankenburg, 1992, The Denver II: a major revision and restandardization of the Denver Developmental Screening Test, Pediatrics, 89, 91, 10.1542/peds.89.1.91 Boppana, 1997, Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection, Pediatrics, 99, 409, 10.1542/peds.99.3.409 Noyola, 2001, Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection, J Pediatr, 138, 325, 10.1067/mpd.2001.112061 Chang, 2007, Neurodevelopment and cognition in children after enterovirus 71 infection, N Engl J Med, 356, 1226, 10.1056/NEJMoa065954 Hallioglu, 2001, Denver developmental screening test II for early identification of the infants who will develop major neurological deficit as a sequalea of hypoxic-ischemic encephalopathy, Pediatr Int, 43, 400, 10.1046/j.1442-200X.2001.01418.x 2009, Cytomegalovirus infection, 275